These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2349693)

  • 1. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective study of cyclosporine monitoring in renal transplantation.
    Lindholm A
    Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
    Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
    Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
    [No Abstract]   [Full Text] [Related]  

  • 5. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary on therapeutic drug monitoring for renal transplantation.
    Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1348-51. PubMed ID: 2190398
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
    Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
    Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
    Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
    Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
    Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
    Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.
    Sollinger HW; Deierhoi M; Kalayoglu M; Belzer FO
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):16-8. PubMed ID: 3515685
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 15. A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
    Fries D; Hiesse C; Charpentier B; Lantz O; Bensadoun H; Benoit G
    Clin Transpl; 1988; ():115-29. PubMed ID: 3154465
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the utility of 3H-based specific monoclonal antibody assay on whole blood samples with the fluorescence polarization nonspecific immunoassay on serum samples for diagnosis of adverse events in renal transplant patients.
    Kahan BD; Napoli K; Welsh M; Grevel J; Rutzky LP
    Transplant Proc; 1990 Jun; 22(3):1274-9. PubMed ID: 2190389
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK; Kupin W; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract]   [Full Text] [Related]  

  • 18. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
    First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.